Researchers studied the effectiveness of new insulin glargine 300 U/mL (Gla-300) vs insulin glargine 100 U/mL (Gla-100) in patients with type 1 diabetes. In two small double-blind, randomized, crossover studies, insulin glargine concentration and glucose infusion rates were more constant and prolonged with Gla-300.
On January 7 at the Consumer Electronic’s Show in Las Vegas, Dexcom presented the first mock-up we’ve ever seen (please see picture) of its Gen 5 CGM integrated directly with an Apple iPhone app and Apple Watch!
Tandem Diabetes Care (San Diego, CA) just announced that the FDA has given clearance to its t:flex insulin pump. Having the largest insulin store of any system available, the t:flex is aimed at diabetics who consume greater quantities of insulin. The reservoir holds 480 units of insulin, which may be sufficient for even the most […]
I’ve heard that not all blood glucose meters are accurate. Can I trust my monitor? And what factors may affect my finger-stick blood sugar results?
Is it common to get bruises at the site of injection? What can you do about that?
Today, Wil goes deep into a question many of us insulin pumpers have asked, about refurbished insulin pumps. Read on to learn whether he thinks there’s any reason for concern…
Here’s a roundup of what we expect to see on the D-Tech scene in 2015, with some insights and observations sprinkled in from our end.
About one-third of people with type 1 diabetes (T1D) produce insulin, as measured by C-peptide, a byproduct of insulin production, even upward of forty years from initial diagnosis, according to a first-of-its-kind, large-scale study.
There is really no medical evidence that intramuscular injections are harmful. They hurt more than subcutaneous injections and people need to use sterile syringes to prevent infection, but otherwise this type of injection can speed up insulin action considerably.
A link between hypoglycaemia and increased risk of cardiovascular events and mortality in patients with diabetes has been confirmed by researchers. The findings could lead to changes in the way some patients’ treatment is managed.
Right before Thanksgiving, Asante Solutions started shipping the first few MySnap insulin pumps to users who ponied up the $99 for the upgrade over the summer. We were able to get our mitts on one of the first for a test drive, and I’ve been wearing it for the last couple of weeks for this […]
A few weeks ago, we posted this story about the inhalable insulin currently on the market. You asked a lot of great questions, and we listened! Here’s Dr. Robert Gabbay, Chief Medical Office at Joslin Diabetes Center, to go a little more in-depth on inhalable insulin.
Today, J&J Animas announced the FDA approval of the Vibe insulin pump integrated with Dexcom’s G4 Platinum CGM for people with diabetes ages 18 and older.
In early November, Novo Nordisk re-launched its Cornerstones4Care program with a new “Diabetes Health Coach” tool. The program is free to the public and aims to provide people with type 1 and type 2 diabetes with individualized, actionable steps towards improving their diabetes management.
The new Software 505 features the same advanced algorithm as used in artificial pancreas research around the world. The software will impact the performance of the Dexcom G4 … already considered the most accurate CGM system on the market today. The software will be made available free of charge to adult patients using the Dexcom […]
If you ask the average person on the street to play a word association game with diabetes, the word “fat” will come up sooner rather than later. Links between obesity and Type 2 diabetes are well established. And yet, not all fat people have diabetes, and not all people with diabetes are fat. Like many […]
The app allows users to manually enter values obtained from external tracking devices, but these devices use different units of measurement to track blood sugar depending on the geographic region of the world they’re sold. For instance, the United States uses mg/dL (milligrams per decilitre), while the UK and Australia use mmol/L (millimoles per litre).
Dexcom, maker of the popular G4 PLATINUM continuous glucometer, received FDA clearance for a new software package for the device that mimics how a natural pancreas assesses sugar levels. Software 505, as it’s called, “features the same advanced algorithm as used in artificial pancreas research around the world,” according to the company.
People who pay for Lantus might be puzzled if they hear that the company that makes the popular insulin is in trouble. In 2013, sales of Lantus earned Sanofi some $8 billion, and the drug company felt comfortable enough to raise the price of its basal insulin twice in a year.
NovioSense, a company out of Nijmegen, Holland, has developed and just received a European patent for a tiny device that is placed in the eye to continuously measure sugar levels in tears.